Lung cancer patients who continue smoking before surgery face higher pulmonary complications but show similar short-term survival rates to those who quit, according to new research from the University of Cincinnati College of Medicine. The findings challenge assumptions about surgical outcomes for patients unable to quit smoking before their procedure.
Pulmonary complications by smoking status in lung cancer surgery
Risk comparison between current smokers and former smokers undergoing resection
complications
mortality
candidacy
Source: University of Cincinnati College of Medicine, 2026 | Georgian Medical Journal News
Study challenges smoking cessation requirements
The University of Cincinnati research examined outcomes for lung cancer patients who underwent surgical resection, comparing those who continued smoking with patients who had stopped before their procedure. The study found that while pulmonary complications occurred more frequently in current smokers, the short-term mortality rates remained statistically similar between groups.
This finding has implications for surgical decision-making, as some centers require smoking cessation before proceeding with lung cancer surgery. The research suggests that continued smoking, while increasing certain risks, should not automatically disqualify patients from potentially life-saving surgery.
Pulmonary complications show clear difference
The study documented significantly higher rates of pulmonary complications among patients who continued smoking compared to former smokers. These complications included pneumonia, prolonged air leaks, and respiratory failure requiring extended mechanical ventilation.
Despite the increased pulmonary complications, researchers found no statistically significant difference in short-term mortality between the smoking groups. This suggests that while smoking increases procedural risks, it does not necessarily translate to higher death rates in the immediate post-operative period, according to clinical outcomes data.
Implications for surgical decision-making
The findings may influence how thoracic surgeons approach patients who are unable or unwilling to quit smoking before lung cancer surgery. Current guidelines often emphasize smoking cessation as a prerequisite for optimal surgical outcomes, but this research provides nuanced data about actual mortality risks.
The research team noted that while smoking cessation remains the ideal scenario for any lung cancer patient, the similar mortality outcomes suggest that surgery should not be delayed indefinitely for patients struggling with tobacco dependence. Early surgical intervention may be more beneficial than postponing treatment while attempting smoking cessation, particularly for aggressive cancer types requiring prompt intervention.
Patients who continue smoking before lung cancer surgery have higher pulmonary complication rates but similar short-term mortality compared to former smokers
— University of Cincinnati College of Medicine researchers (Medical Xpress, 2026)
Key takeaways
- Short-term mortality rates are similar between current smokers and former smokers undergoing lung cancer surgery
- Pulmonary complications occur more frequently in patients who continue smoking before surgery
- Continued smoking may not warrant automatic disqualification from surgical treatment
- Timing of surgical intervention should balance smoking status with cancer progression risks
Frequently asked questions
Should lung cancer patients delay surgery to quit smoking?
The research suggests that while smoking cessation is beneficial, delaying surgery indefinitely may not be warranted given similar mortality outcomes. The decision should balance individual cancer characteristics with the patient’s ability to quit smoking.
What specific complications are more common in smoking patients?
Current smokers face higher risks of pneumonia, prolonged air leaks, and respiratory failure requiring mechanical ventilation. However, these complications did not translate to higher short-term death rates in this study.
How should surgeons counsel patients who cannot quit smoking?
Surgeons should provide clear information about increased complication risks while reassuring patients that similar mortality outcomes support proceeding with necessary cancer treatment. Smoking cessation support should continue throughout the treatment process.
The University of Cincinnati findings contribute important nuance to lung cancer surgery guidelines, suggesting that surgical candidacy decisions should consider the full spectrum of risks and benefits rather than focusing solely on smoking status. As lung cancer treatment continues to evolve, this research supports individualized treatment approaches that prioritize timely intervention while managing known risk factors. The study reinforces that smoking cessation remains important for overall health outcomes, but should not become a barrier to essential cancer treatment when patients are unable to quit before surgery.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
